API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

Clascoterone skin care

Clascoterone (cortexolone 17α-propionate, CB-03-01) is a novel antagonist of androgen receptors. It binds to androgen receptors with high affinity.

Dec 14,2021  API

Side effects of Nilotinib Hydrochloride Monohydrate

?Nilotinib (AMN107, trade name Tasigna) has a number of adverse effects typical of anti-cancer drugs: a headache, fatigue, gastrointestinal problems such as nausea, vomiting, diarrhea and constipation

Dec 14,2021  API

Phenacetin

Phenacetin (p-Acetophenetidine),is an acetanilide antipyretic and analgesic, and its antipyretic and analgesic effect is mild and lasting. The antipyretic strength is similar to that of aspirin, but t

Dec 10,2021  API

4'-Methylacetophenone

P-methylacetophenone is a colorless needle-like crystal or a colorless to almost colorless liquid. This product has a fragrance similar to Crataegus flower, and has the fragrance of alfalfa, honey, an

Dec 10,2021  API

Side effects of Arbidol Hydrochloride

Arbidol hydrochloride has the effect of an immunomodulator and also has special antiviral activity against influenza A and influenza B.

Dec 10,2021  API

Synthesis and reactions of Isoamyl nitrite

Isoamyl nitrite is a nitrite ester having isopentyl as the alkyl group. It has a role as a vasodilator agent and an antihypertensive agent. It derives from an isoamylol.

Dec 10,2021  API

Uses of Carbamazepine

Carbamazepine is a synthetic iminostilbene derivative structurally similar to imipramine, a tricyclic antidepressant. While unrelated structurally, carbamazepine shares a similar therapeutic action wi

Dec 8,2021  API

Application and Pharmacology of Lorcaserin hydrochloride

Lorcaserin hydrochloride is a hydrochloride obtained by reaction of lorcaserin with one equivalent of hydrochloric acid. Used as an anti-obesity drug. It has a role as a serotonergic agonist and an ap

Dec 7,2021  API

Toxicity of 3-Quinuclidinyl benzilate

3-Quinuclidinyl benzilate (QNB) — IUPAC name 1-azabicyclo[2.2.2]octan-3-yl hydroxy(diphenyl)acetate; US Army code EA-2277; NATO code BZ; Soviet code Substance 78— is an odorless and bitter-tasting mil

Dec 3,2021  API

Uses of Busulfan

Busulfan was noted to have strong antitumor activity in the 1950s. Because of this, GlaxoSmithKline developed the compound, launching Myleran in 1954 for the treatment of chronic myelogenous leukemia

Nov 30,2021  API
Prev12345678910...Next>  Go to Page